Clinical Study of Lipoic Acid on Ischemic Heart Failure

NCT03491969 ↗

Phase 4 Completed 300 enrolled Shanghai Zhongshan Hospital

RandomizedSequentialDouble-blindOther

Summary

The study will evaluate the efficacy of alpha-lipoic acid(α-LA) on mortality in patients with ischemic heart failure (NYHA Class II - IV and EF =\< 50%).

Timeline

Start: 2019-01-01
Primary completion: 2025-02-01
Completion: 2025-02-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	alpha-lipoic acid	Small molecule	200 mg	Oral

Clinical Study of Lipoic Acid on Ischemic Heart Failure

Summary

Timeline

Drugs

Indications